Skip to content
Recall Observatory FDA recall evidence

Drug product

Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.

D-1206-2018

August 21, 2018

Class I

Product summary

Firm
Accord Healthcare, Inc.
Event
Event 80850
Status
Terminated
Classification
Class I
Quantity
46,632 bottles
Official record key
drug-enforcement:D-1206-2018

Official wording

Reason: Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.

Code information: Lot: PW05264, Exp. 11/2019

Distribution pattern: Nationwide in the USA and Puerto Rico.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.